SOL [ReneSola] 6-K: RENESOLA LTD AND THE BANK OF NEW YORK

[RENESOLA LTD AND THE BANK OF NEW YORK MELLON, RIGHTS AGENT RIGHTS AGREEMENT RIGHTS AGREEMENT Dated as of August 22, 2011 (the “Agreement”), between ReneSola Ltd, a company incorporated with limited liability in British Virgin Islands under the BVI Business Companies Act (the “Company”), and The Bank of New York Mellon, a New York banking corporation (in its capacity as] [STANDSTILL AGREEMENT Agreement Company Mr. Li THIS STANDSTILL AGREEMENT (this “ Rights Agreement WHEREAS, the Company has agreed to provide Mr. Li with certain exceptions from restrictions in that certain rights agreement, dated as of August 22, 2011, between the Company and Bank of New York Mellon, as rights agent (the “ NOW THEREFORE, in consideration of the foregoing and] [ReneSola Adopts Shareholder Rights Plan JIASHAN, China, August 22, 2011 – ReneSola Ltd (NYSE: SOL) (“ReneSola” or the “Company”), a leading global manufacturer of solar products, today announced that its Board of Directors has adopted a shareholder rights plan (the “Rights Plan”) to protect the best interests of the Company and its shareholders. One ordinary share purchase right (a “Right”)] [RENESOLA LTD No. 8 Baoqun Road Yaozhuang Town Jiashan County, Zhejiang 314117 People’s Republic of China x ¨ Form 20-F ¨ x Yes N/A 82- ____ RENESOLA LTD Form 6-K TABLE OF CONTENTS 3 Incorporation by Reference]

By | 2016-03-27T12:26:10+00:00 August 22nd, 2011|Categories: Chinese Stocks, SOL, Webplus ver|Tags: , , , , , |0 Comments

YGE [YINGLI GREEN ENERGY] 6-K: Yingli Green Energy Reports Second Quarter 2011 Results

[Yingli Green Energy Reports Second Quarter 2011 Results STYLE="font-family:Times New Roman" SIZE="2"> Quarterly Shipmentreased by 36.6% to Reach a Historical High Diluted EPS Was US$0.36 BAODING, China, August19, 2011 Second Quarter 2011nsolidated Financial and Operating Highlights Total net revenuesreased by 27.4% to RMB 4,398.8million (US$680.6 million) from the first quarter of 2011.]

By | 2016-02-04T01:04:43+00:00 August 22nd, 2011|Categories: Chinese Stocks, Webplus ver, YGE|Tags: , , , , , |0 Comments

CPGI [China Shengda Packaging] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 19, 2011 CHINA SHENGDA PACKAGING GROUP INC Nevada 333-168307 26-1559574 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) No. 2 Beitang Road Xiaoshan Economic and Technological Development Zone Hangzhou, Zhejiang Province 311215 People's Republic of China (86) 571-82838805 _______________________________________________ see [ ] []

By | 2016-03-08T21:56:22+00:00 August 22nd, 2011|Categories: Chinese Stocks, CPGI, SEC Original|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] CORRESP: (Original Filing)

[Tianyin Pharmaceutical Co., Inc. NYSE Amex: TPI rd 23 August 22, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Frank Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2010 File No. 001-34189 Dear Mr. Wyman: This letter is provided in response to your letter dated June 10, 2011 regarding the]

By | 2016-03-27T20:25:24+00:00 August 22nd, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of June 30, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements ofome and Othermprehensiveomefor the Six Months Ended June 30, 2011 and 2010 (unaudited)] [CERTIFICATION I, WeibingLu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. WeibingLu v233000_ex32-1.htm 4 EX-32.1] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Bing Mei Bing Mei Chief Financial Officer (Principal Accounting and Financial Officer) v233000_ex32-2.htm 5 EX-32.2]

By | 2016-02-05T03:32:18+00:00 August 22nd, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

CPGI [China Shengda Packaging] 8-K: FORM 8-K CURRENT REPORT Date of Report (Date

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 19, 2011 CHINA SHENGDA PACKAGING GROUP INC Nevada 333-168307 26-1559574 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) No. 2 Beitang Road Xiaoshan Economic and Technological Development Zone Hangzhou, Zhejiang Province 311215 People's Republic of China (86) 571-82838805 _______________________________________________ see [ ] []

By | 2016-03-08T21:57:43+00:00 August 22nd, 2011|Categories: Chinese Stocks, CPGI, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] CORRESP: Tianyin Pharmaceutical Co., Inc. NYSE Amex: TPI rd

[Tianyin Pharmaceutical Co., Inc. NYSE Amex: TPI rd 23 August 22, 2011 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Frank Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2010 File No. 001-34189 Dear Mr. Wyman: This letter is provided in response to your letter dated June 10, 2011 regarding the]

By | 2016-03-27T20:26:25+00:00 August 22nd, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of June 30, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements ofome and Othermprehensiveomefor the Six Months Ended June 30, 2011 and 2010 (unaudited)] [CERTIFICATION I, WeibingLu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofYSTARBIO-PHARMACEUTICALCOMPANY; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. WeibingLu v233000_ex32-1.htm 4 EX-32.1] [CERTIFICATION (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Bing Mei Bing Mei Chief Financial Officer (Principal Accounting and Financial Officer) v233000_ex32-2.htm 5 EX-32.2]

By | 2016-02-05T03:33:09+00:00 August 22nd, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q/A: (Original Filing)

[FORM 10-Q/A (Amendment No. 1) (Mark One) For the quarterly period ended March 31, 2011 For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Chief Accounting Officer, Chief Business and Development Officer,]

By | 2016-03-27T20:27:37+00:00 August 22nd, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Skip to toolbar